Amgen Inc. discovers, develops, manufactures and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. It has agreements with Novartis, Bayer, among others.
Revenue TTM 25.7B
Net Income TTM 5.6B
EBITDA TTM 12.1B
EBITDA margin TTM 47.1%.
Debt/EBITDA TTM 3.05x
Revenue TTM 25.7B
Net Income TTM 5.6B
EBITDA TTM 12.1B
EBITDA margin TTM 47.1%.
Debt/EBITDA TTM 3.05x
أغلقت الصفقة: تم الوصول للهدف:
Dec 16